SEC Form 4Coverage since Jun 25, 2026
$LEGN insider trading
Over the last 12 months, Legend Biotech insiders reported no purchases and 2 sales totaling $171K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $171K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $LEGN · 12Mvia TradingView
Top insiders · 12m
Huang YingChief Executive Officer1× · $82K
Casey Patrick John—1× · $89K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Casey Patrick JohnD | ▼ Sale | 6,000 | $14.8 | $89K | -11% | — |
| Jun 25, 2026 | Huang YingChief Executive Officer · O·D | ▼ Sale | 5,566 | $14.78 | $82K | -2.2% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $LEGN feed.